标记临床研究 XOMA 深 沪
已收盘 07-14 16:00:00 美东时间
40.17
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 40.17
- 总市值 7.10亿
- 52周最高 45.22
- 市盈率 静 27.59
- 换手率 0.00%
- 52周最低 22.29
- 委 比 0.00%
- 总股本 1767.87万
- 历史最高 191.40
- 量 比 0
- 振 幅 0.00%
- 历史最低 3.96
- 每 手 1
- 风险率 6.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Ligand Pharmaceuticals completed its acquisition of XOMA Royalty for $739 million, adding seven commercial products, over 100 development assets, and enhancing its portfolio to over 200 assets. The deal is expected to boost Ligand's earnings and strengthen its position as a leading biopharmaceutical royalty aggregator. Ligand will provide a 5-year outlook during its Investor Day in December 2026.
07-14 13:00
Longeveron® Appoints Marie Washburn as Chief Financial Officer
Longeveron Inc. appoints Marie Washburn as Senior Vice President and Chief Financial Officer, effective July 13, 2026. With over 20 years of leadership experience in the pharmaceutical and biotech sectors, Washburn previously served as Vice President and Corporate Controller at the company. Her appointment comes as Longeveron anticipates top-line results from its Phase 2b clinical trial for laromestrocel in treating Hypoplastic Left Heart Syndrom...
07-06 20:05
Ligand prices proposed $550M convertible senior notes offering
Ligand Pharmaceuticals (LGND) said on Monday it plans to offer $550M of convertible senior notes due 2031 in a private placement and expects to grant initial purchasers a 13-day option to buy up to an...
06-22 19:33
XOMA Details Merger Timeline and Preferred Share Redemption
An update from XOMA Royalty Corporation ( ($XOMA) ) is now available. On June 1...
06-13 07:53
XOMA Preferred Shares Series A declares $0.539 dividend
XOMA Preferred Shares Series A (XOMAP) declares $0.539/share quarterly dividend, in line with previous. Forward yield 8.47% Payable July 15; for shareholders of record July 2; ex-div July 2. See XOMAP...
06-13 04:14
XOMA Royalty Corporation Declares Quarterly Preferred Stock Dividend and Announces Redemption of Its Perpetual Preferred Stock and CVR Dividend Record Date
XOMA Royalty Corporation announced that its Board of Directors has authorized cash dividends for holders of its Series A and Series B Preferred Stock, with dividends of $0.53906 per share for Series A and $0.52344 per depositary share for Series B. The Preferred Stock will be redeemed on July 14, 2026, at $25.00 per share or depositary share. Dividends will be paid on July 15, 2026, to holders of record as of July 2, 2026. The redemption is part ...
06-12 20:05
XOMA Royalty amends merger agreement with Ligand Pharmaceuticals
An announcement from XOMA Royalty Corporation ( ($XOMA) ) is now available. On ...
05-18 22:08
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
Ligand to buy XOMA Royalty for $39/share
Ligand Pharmaceuticals (LGND) has agreed to acquire XOMA Royalty (XOMA) for $39.00 per share of common stock in cash, for a total equity value of approximately $739M. The transaction has been unanimou...
04-27 19:32
Ligand Pharmaceuticals To Acquire XOMA Royalty For $39.00 Per Share In Cash, Ligand Raises FY2026 Adj. EPS Guidance To $8.50-9.50 And Expects The Transaction To Be Accretive By $1.50 Per Share To Adj. EPS In 2027
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA), both biotechnology royalty aggregators, today announced that the companies have entered into a definitive
04-27 19:06
